Active (not recruiting) Phase 1 2025-522402-21-00

A first study in humans testing the safety and effects of KUP-101A in patients with certain advanced solid cancers

Phase 1 – testing safety in a small group of people

Conditions: Advanced solid tumors (cutaneous melanoma mucosal melanoma cutaneous squamous cell carcinoma Merkel cell carcinoma or basal cell carcinoma)

Sponsor: Kupando GmbH

trial.available_in:

БГ

Overview

Trial status: Authorised

Who can participate

Age group: 18-64 years, 65+ years Gender: Female, Male Target enrollment: 21 participants

Locations 1

Germany (1)

Status

Active (not recruiting)

Phase

Phase 1

Study type

INTERVENTIONAL

Sex

Male and female

Minimum age

18 Years

Healthy volunteers

Start date

12.11.2025

Registry ID

2025-522402-21-00

Source

euclinicaltrials.eu

trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.